Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""DiSilvestro PA"" wg kryterium: Autor


Wyświetlanie 1-4 z 4
Tytuł:
The Perfect Combination: Enhancing Patient Response to PD-1-Based Therapies in Epithelial Ovarian Cancer.
Autorzy:
James NE; Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants Hospital, Providence, RI 02905, USA.
Woodman M; Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants Hospital, Providence, RI 02905, USA.
DiSilvestro PA; Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants Hospital, Providence, RI 02905, USA.; Department of Obstetrics and Gynecology, Warren Alpert School of Medicine, Brown University, Providence, RI 02903, USA.
Ribeiro JR; Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants Hospital, Providence, RI 02905, USA.; Department of Obstetrics and Gynecology, Warren Alpert School of Medicine, Brown University, Providence, RI 02903, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2020 Aug 03; Vol. 12 (8). Date of Electronic Publication: 2020 Aug 03.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes.
Autorzy:
James NE; Women and Infants Hospital, Department of Obstetrics and Gynecology, Program in Women's Oncology, Providence, RI, USA.
Emerson JB; Women and Infants Hospital, Department of Obstetrics and Gynecology, Program in Women's Oncology, Providence, RI, USA.; Warren-Alpert Medical School of Brown University, Providence, RI, USA.
Borgstadt AD; Women and Infants Hospital, Department of Obstetrics and Gynecology, Program in Women's Oncology, Providence, RI, USA.; Warren-Alpert Medical School of Brown University, Providence, RI, USA.
Beffa L; Women and Infants Hospital, Department of Obstetrics and Gynecology, Program in Women's Oncology, Providence, RI, USA.; Warren-Alpert Medical School of Brown University, Providence, RI, USA.
Oliver MT; Women and Infants Hospital, Department of Obstetrics and Gynecology, Program in Women's Oncology, Providence, RI, USA.; Warren-Alpert Medical School of Brown University, Providence, RI, USA.
Hovanesian V; Rhode Island Hospital, Digital Imaging and Analysis Core Facility, Providence, RI, USA.
Urh A; Northwell Health Physician Partners Gynecologic Oncology, Brightwaters, NY, USA.
Singh RK; University of Rochester Medical Center, Rochester, NY, USA.
Rowswell-Turner R; University of Rochester Medical Center, Rochester, NY, USA.
DiSilvestro PA; Women and Infants Hospital, Department of Obstetrics and Gynecology, Program in Women's Oncology, Providence, RI, USA.; Warren-Alpert Medical School of Brown University, Providence, RI, USA.
Ou J; Warren-Alpert Medical School of Brown University, Providence, RI, USA.; Women and Infants Hospital, Department of Pathology, Providence, RI, USA.
Moore RG; University of Rochester Medical Center, Rochester, NY, USA.
Ribeiro JR; Women and Infants Hospital, Department of Obstetrics and Gynecology, Program in Women's Oncology, Providence, RI, USA. .; Warren-Alpert Medical School of Brown University, Providence, RI, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 May 22; Vol. 10 (1), pp. 8558. Date of Electronic Publication: 2020 May 22.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Biomarkers, Tumor/*metabolism
Neovascularization, Pathologic/*pathology
Ovarian Neoplasms/*pathology
STAT3 Transcription Factor/*metabolism
Tumor Microenvironment/*immunology
WAP Four-Disulfide Core Domain Protein 2/*metabolism
Adult ; Biomarkers, Tumor/genetics ; Case-Control Studies ; Cell Movement ; Cell Proliferation ; Female ; Follow-Up Studies ; Humans ; Middle Aged ; Neovascularization, Pathologic/genetics ; Neovascularization, Pathologic/metabolism ; Ovarian Neoplasms/blood supply ; Ovarian Neoplasms/immunology ; Ovarian Neoplasms/metabolism ; Prognosis ; STAT3 Transcription Factor/genetics ; Tumor Cells, Cultured ; WAP Four-Disulfide Core Domain Protein 2/genetics
Czasopismo naukowe
Tytuł:
HE4 suppresses the expression of osteopontin in mononuclear cells and compromises their cytotoxicity against ovarian cancer cells.
Autorzy:
James NE; Department of Obstetrics and Gynecology, Program in Women's Oncology, Women and Infants Hospital, The Warren Alpert Medical School of Brown University, Providence, RI, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
Cantillo E; Department of Obstetrics and Gynecology, Program in Women's Oncology, Women and Infants Hospital, The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Oliver MT; Department of Obstetrics and Gynecology, Program in Women's Oncology, Women and Infants Hospital, The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Rowswell-Turner RB; Department of Pharmacy, University of Rhode Island, Kingston, RI, USA.
Ribeiro JR; Department of Obstetrics and Gynecology, Program in Women's Oncology, Women and Infants Hospital, The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Kim KK; Department of Pharmacy, University of Rhode Island, Kingston, RI, USA.
Chichester CO 3rd; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
DiSilvestro PA; Department of Obstetrics and Gynecology, Program in Women's Oncology, Women and Infants Hospital, The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Moore RG; Department of Pharmacy, University of Rhode Island, Kingston, RI, USA.
Singh RK; Department of Obstetrics and Gynecology, Program in Women's Oncology, Women and Infants Hospital, The Warren Alpert Medical School of Brown University, Providence, RI, USA.; Department of Pharmacy, University of Rhode Island, Kingston, RI, USA.
Yano N; Department of Obstetrics and Gynecology, Program in Women's Oncology, Women and Infants Hospital, The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Zhao TC; Department of Surgery, Roger Williams Medical Center, Providence, RI, USA.
Pokaż więcej
Źródło:
Clinical and experimental immunology [Clin Exp Immunol] 2018 Sep; Vol. 193 (3), pp. 327-340.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Dual Specificity Phosphatase 6/*metabolism
Leukocytes, Mononuclear/*physiology
Osteopontin/*metabolism
Ovarian Neoplasms/*immunology
Proteins/*metabolism
T-Lymphocytes/*immunology
Cell Line, Tumor ; Cell Proliferation ; Cytotoxicity, Immunologic ; Dual Specificity Phosphatase 6/genetics ; Female ; Gene Expression Regulation ; Humans ; Immune Tolerance ; Interferon-gamma/metabolism ; Interleukin-12/metabolism ; Osteopontin/genetics ; Ovarian Neoplasms/mortality ; Proteins/genetics ; RNA, Small Interfering/genetics ; Survival Analysis ; Tumor Escape ; Tumor Microenvironment ; WAP Four-Disulfide Core Domain Protein 2
Czasopismo naukowe
    Wyświetlanie 1-4 z 4

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies